🎥 The Doc Returns to Talk Insurance

In the past couple of decades, attitudes toward cannabis have started to shift - especially among medical professionals.

 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Browser View

Dr. Tishler Returns: Medical Market, Insurance, Opioids and More Matthew Carr, Chief Trends Strategist, The Oxford Club   The Most Successful Store in America? This nondescript red building holds one of the most successful stores in America. It brings in more cash than Starbucks, Tiffany & Co. and even Apple. Find out here why these businesses will soon be in cities all over America.   Investors are laser-focused on the adult-use market. But there's a persuasive argument to be made that the medical market will be larger. That's because cannabis has a wide range of medical uses. And it wasn't until recently that marijuana was considered to be a "dangerous drug." Five thousand years ago, Chinese emperor Shen Nung prescribed cannabis for a number of different ailments. In ancient India, it was seen as a gift from the gods. And in Materia Medica, published in A.D. 70, Roman physician Pedanius Dioscorides recommended cannabis for earaches and diminished libido. It wasn't until the 1990s that scientists discovered humans had an endocannabinoid system - an entire pathway that reacts to cannabis and affects appetite, memory, energy, stress responses, immune functions, sleep and more. In the couple of decades since, attitudes toward cannabis have started to shift - especially among medical professionals. In today's episode of CannaBiz Now! I sat down once again with Dr. Jordan Tishler. The Harvard-trained physician is president of the Association of Cannabis Specialists and founder of the practice Inhale MD. He shared with us the most common - and most effective - ailments he prescribes cannabis for. For one condition, he even dubbed cannabis the "knight on the white horse" (and it's not pain or cancer). Dr. Tishler also explained what he thinks is ahead for medical cannabis. And we delved into cannabis' ability to battle the opioid crisis - as either an alternative or a treatment. Lastly, Dr. Tishler shared how big he thinks the medical marijuana market will ultimately be. As with all our interviews with Dr. Tishler, you'll walk away with new insights and knowledge - an imperative in today's rapidly changing cannabis industry. Click here to watch today's episode. Here's to high returns, Matthew P.S. In just a few weeks, we'll finally reveal our brand makeover, reflecting our name change to Profit Trends. You'll soon receive more details on how to ensure you continue receiving features like CannaBiz Now!   Be Resourceful: Share With a Friend   — More From Energy & Resources Digest —     3 Energy Plays to Watch Three stocks in the energy sector are really moving... Let's catch up.   Best-Performing Pot Stocks Following 4/20 2018 In 2018, 4/20 marked the beginning of a blazing run for a number of cannabis companies.   Canopy to Acquire Acreage in Biggest Cannabis M&A Deal Ever Canopy Growth has secured the right to snatch up the largest MSO in the U.S. for a whopping $3.4 billion.       Are You a Man Who Feels Fat, Old, Achy, Cranky, Limp-Noodled and Tired?     First of all, you DON'T have to feel this way. Scientific research confirms that you're not SUPPOSED to. If you do, it may be because of a chemical the CDC reports is affecting "95% of the U.S. population." The good news is, there's a simple fix that could see you feeling fit, strong, capable, energized and rock-hard in no time (and at any age). CLICK HERE to learn more.   You are receiving this email because you subscribed to Energy & Resources Digest. To unsubscribe from Energy & Resources Digest, click here. Questions? Check out our FAQs. Trying to reach us? Contact us here. Please do not reply to this email as it goes to an unmonitored inbox. To cancel by mail or for any other subscription issues, write us at: Energy & Resources Digest | Attn: Member Services | 105 West Monument Street | Baltimore, MD 21201 North America: 1.800.683.0709 | International: +1.443.353.4747 | Fax: 1.410.329.1923 Website: www.energyandresourcesdigest.com Keep the emails you value from falling into your spam folder. Whitelist Energy & Resources Digest. © 2019 The Oxford Club LLC All Rights Reserved   The Oxford Club is a financial publisher that does not offer any personal financial advice or advocate the purchase or sale of any security or investment for any specific individual. Members should be aware that although our track record is highly rated by an independent analysis and has been legally reviewed, investment markets have inherent risks and there can be no guarantee of future profits. The stated returns may also include option trades. We expressly forbid our writers from having a financial interest in their own securities recommendations to readers. All of our employees and agents must wait 24 hours after online publication or 72 hours after the mailing of printed-only publications prior to following an initial recommendation. Any investments recommended by The Oxford Club should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. The information found on this website may only be used pursuant to the membership or subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of The Oxford Club, 105 W. Monument Street, Baltimore MD 21201.